Redpin Therapeutics (Series A)
Funding Details
Awarder
Inbox
Date Award
March 25, 2020
Vertical
Gene Therapy
Funding URL
View Funding Page
Funding Amount
$15,500,000
Company Info
Founders
Elma S. Hawkins
Market
Central Nervous System Diseases
Location
New York, NY, USA
Coinvestors
4BIO Capital, Alexandria Venture Investments, Arkin Bio Ventures, New York Ventures, Takeda Ventures
Company Description

Redpin Therapeutics is a preclinical stage gene therapy company that develops chemogenetics platform designed for nervous system diseases.

Links
WebsiteCrunchbaseLinkedIn
Back to HomeBack to Gene Therapy DealsView Funding Announcement